Y. Matsuzaki

发表

Apoptosis and inhibition of the phosphatidylinositol 3-kinase/Akt signaling pathway in the anti-proliferative actions of dehydroepiandrosterone

Yanfang Jiang, T. Miyazaki, A. Honda, 2005, Journal of Gastroenterology.

Agaro-Oligosaccharides Regulate Gut Microbiota and Adipose Tissue Accumulation in Mice.

Y. Baba, Y. Naito, A. Honda, 2017, Journal of nutritional science and vitaminology.

Efficacy of pitavastatin for the treatment of non‐alcoholic steatohepatitis with dyslipidemia: An open‐label, pilot study

Y. Matsuzaki, S. Tazuma, K. Inui, 2011, Hepatology research : the official journal of the Japan Society of Hepatology.

Optimal and effective oral dose of taurine to prolong exercise performance in rat

T. Miyazaki, N. Tanaka, Y. Matsuzaki, 2004, Amino Acids.

Human-specific dual regulations of FXR-activation for reduction of fatty liver using in vitro cell culture model

T. Miyazaki, A. Honda, Y. Matsuzaki, 2018, Journal of clinical biochemistry and nutrition.

Cholesterol 25-hydroxylation activity of CYP3A

T. Miyazaki, A. Honda, Takeshi Hirayama, 2011, Journal of Lipid Research.

Disrupted coordinate regulation of farnesoid X receptor target genes in a patient with cerebrotendinous xanthomatosis Published, JLR Papers in Press, December 1, 2004. DOI 10.1194/jlr.M400256-JLR200

A. Honda, Takeshi Hirayama, Y. Matsuzaki, 2005, Journal of Lipid Research.

Dietary cholesterol stimulates CYP7A1 in rats because farnesoid X receptor is not activated.

A. Honda, Y. Matsuzaki, Guorong Xu, 2004, American journal of physiology. Gastrointestinal and liver physiology.

FXR-mediated down-regulation of CYP7A1 dominates LXRalpha in long-term cholesterol-fed NZW rabbits.

F. Suchy, B. M. Forman, A. Honda, 2003, Journal of lipid research.

Selective inhibition of CYP27A1 and of chenodeoxycholic acid synthesis in cholestatic hamster liver.

A. Honda, S. Yoshida, N. Tanaka, 2002, Biochimica et biophysica acta.

Clinical Features of Gastroduodenal Ulcer in Japanese Patients Taking Low-Dose Aspirin

A. Honda, Takeshi Hirayama, Y. Matsuzaki, 2010, Digestive Diseases and Sciences.

Highly sensitive quantification of 7alpha-hydroxy-4-cholesten-3-one in human serum by LC-ESI-MS/MS.

A. Honda, Y. Matsuzaki, T. Ikegami, 2007, Journal of lipid research.

pH‐dependent uptake of irinotecan and its active metabolite, SN‐38, by intestinal cells

S. Kudoh, Y. Matsuzaki, Kunihiko Kobayashi, 1999, International journal of cancer.

Abstracts of selected papers presented at the 30th Annual Meeting of the Japanese Society of Gastroenterology October 20–22, 1988 — Kagoshima, Japan

S. Kawasaki, T. Yamakawa, K. Tanikawa, 1991, Gastroenterologia Japonica.

Symptoms and health-related quality of life in Japanese patients with primary biliary cholangitis

H. Yoshiji, A. Komori, A. Takaki, 2018, Scientific Reports.

Is patient-reported outcome improved by nalfurafine hydrochloride in patients with primary biliary cholangitis and refractory pruritus? A post-marketing, single-arm, prospective study

H. Yoshiji, A. Honda, Y. Matsuzaki, 2018, Journal of Gastroenterology.

Increased serum liver X receptor ligand oxysterols in patients with non-alcoholic fatty liver disease

T. Miyazaki, A. Honda, Y. Matsuzaki, 2012, Journal of Gastroenterology.

Serum Amino Acid Profiling in Citrin-Deficient Children Exhibiting Normal Liver Function During the Apparently Healthy Period.

H. Tsukahara, K. Ihara, T. Miyazaki, 2019, JIMD reports.

Influencing factors on serum 25-hydroxyvitamin D3 levels in Japanese chronic hepatitis C patients

A. Tsubota, Y. Matsuzaki, K. Iwakiri, 2015, BMC Infectious Diseases.

Bile acid synthesis in the Smith-Lemli-Opitz syndrome: effects of dehydrocholesterols on cholesterol 7alpha-hydroxylase and 27-hydroxylase activities in rat liver.

A. Honda, N. Tanaka, Y. Matsuzaki, 1999, Journal of lipid research.

Differences in hepatic levels of intermediates in bile acid biosynthesis between Cyp27(-/-) mice and CTX.

A. Honda, N. Tanaka, Y. Matsuzaki, 2001, Journal of lipid research.

Highly sensitive and specific analysis of sterol profiles in biological samples by HPLC–ESI–MS/MS

T. Miyazaki, A. Honda, Y. Matsuzaki, 2010, The Journal of Steroid Biochemistry and Molecular Biology.

Regulatory T cells and liver pathology in a murine graft versus host response model

T. Miyazaki, A. Honda, Y. Matsuzaki, 2009, Hepatology research : the official journal of the Japan Society of Hepatology.

Intestinal alkalization as a possible preventive mechanism in irinotecan (CPT-11)-induced diarrhea.

Y. Matsuzaki, Kunihiko Kobayashi, P. Latham, 2002, Cancer research.

The expression levels of plasma membrane transporters in the cholestatic liver of patients undergoing biliary drainage and their association with the impairment of biliary secretory function

Y. Sugiyama, Y. Nimura, N. Tanaka, 2001, American Journal of Gastroenterology.

Efficacy and safety of ombitasvir/paritaprevir/ritonavir combination therapy for genotype 1b chronic hepatitis C patients complicated with chronic kidney disease

A. Tsubota, Etsuko Iio, Yasuhito Tanaka, 2018, Hepatology research : the official journal of the Japan Society of Hepatology.

Liver Fibrosis: Possible Involvement of EMT

Y. Matsuzaki, T. Ikegami, Yining Zhang, 2007, Cells Tissues Organs.

Post‐therapeutic needle biopsy in patients with hepatocellular carcinoma is a useful tool to evaluate response to proton irradiation

H. Tsujii, A. Honda, Y. Matsuzaki, 2014, Hepatology research : the official journal of the Japan Society of Hepatology.

Efficacy of direct‐acting antiviral treatment in patients with compensated liver cirrhosis: A multicenter study

A. Tsubota, Etsuko Iio, Yasuhito Tanaka, 2018, Hepatology research : the official journal of the Japan Society of Hepatology.

Ledipasvir‐sofosbuvir for treating Japanese patients with chronic hepatitis C virus genotype 2 infection

N. Enomoto, Y. Takikawa, Y. Asahina, 2018, Liver international : official journal of the International Association for the Study of the Liver.

Randomized phase 3 trial of ombitasvir/paritaprevir/ritonavir for hepatitis C virus genotype 1b–infected Japanese patients with or without cirrhosis

K. Chayama, Y. Karino, M. Patwardhan, 2015, Hepatology.

Immunohistochemical study of cytochrome P450 2C and 3A in human non-neoplastic and neoplastic tissues

T. Shimada, Y. Matsuzaki, M. Kakiki, 1999, Virchows Archiv.

Clinical significance of the trimethadione tolerance test in chronic hepatitis: A useful indicator of hepatic drug metabolizing capacity

N. Tanaka, Y. Matsuzaki, T. Osuga, 1995, Journal of Gastroenterology.

High prevalence of hepatitis B and C viral markers in Japanese patients with hepatocellular carcinoma

N. Tanaka, Y. Matsuzaki, T. Chiba, 1993, Gastroenterologia Japonica.

Multivariate analysis of risk factors for hepatocellular carcinoma in patients with hepatitis C virus-related liver cirrhosis

N. Tanaka, Y. Matsuzaki, T. Chiba, 1996, Journal of Gastroenterology.

Increased serum oxysterol concentrations in patients with chronic hepatitis C virus infection.

T. Miyazaki, A. Honda, Y. Matsuzaki, 2014, Biochemical and biophysical research communications.

The protective effect of taurine against hepatic damage in a model of liver disease and hepatic stellate cells.

T. Miyazaki, A. Honda, Y. Matsuzaki, 2009, Advances in experimental medicine and biology.

Combined effect of branched-chain amino acids and taurine supplementation on delayed onset muscle soreness and muscle damage in high-intensity eccentric exercise

T. Miyazaki, Y. Matsuzaki, Y. Nakata, 2013, Journal of the International Society of Sports Nutrition.

Clinical features of gastroduodenal injury associated with long-term low-dose aspirin therapy.

A. Honda, Y. Matsuzaki, Y. Saito, 2013, World journal of gastroenterology.

Microanalysis of bile acid composition in intrahepatic calculi and its etiological significance.

A. Honda, N. Tanaka, Y. Matsuzaki, 1991, Gastroenterology.

Taurine and liver diseases: a focus on the heterogeneous protective properties of taurine

T. Miyazaki, Y. Matsuzaki, 2012, Amino Acids.

Side Chain Hydroxylations in Bile Acid Biosynthesis Catalyzed by CYP3A Are Markedly Up-regulated in Cyp27−/− Mice but Not in Cerebrotendinous Xanthomatosis*

A. Honda, N. Tanaka, Y. Matsuzaki, 2001, The Journal of Biological Chemistry.

Determination of Key Intermediates in Cholesterol and Bile Acid Biosynthesis by Stable Isotope Dilution Mass Spectrometry

A. Honda, Y. Matsuzaki, Tadashi Yoshida, 2008, Analytical chemistry insights.

Proton beam therapy for hepatocellular carcinoma with inferior vena cava tumor thrombus: report of three cases.

T. Hashimoto, Y. Akine, Y. Matsuzaki, 2007, Japanese journal of clinical oncology.

Changes in G protein expression account for impaired modulation of hepatic cAMP formation after BDL.

Y. Matsuzaki, T. Gettys, B. Bouscarel, 1998, American journal of physiology. Gastrointestinal and liver physiology.

The harmful effect of exercise on reducing taurine concentration in the tissues of rats treated with CCl4 administration

T. Miyazaki, N. Tanaka, Y. Matsuzaki, 2004, Journal of Gastroenterology.

Amino acid ratios in plasma and tissues in a rat model of liver cirrhosis before and after exercise.

T. Miyazaki, N. Tanaka, Y. Matsuzaki, 2003, Hepatology research : the official journal of the Japan Society of Hepatology.

Increase of deoxycholate in supersaturated bile of patients with cholesterol gallstone disease and its correlation with de novo syntheses of cholesterol and bile acids in liver, gallbladder emptying, and small intestinal transit

N. Tanaka, Y. Matsuzaki, Hiroshi Miyazaki, 1995, Hepatology.

Metabolism and hepatic toxicity of flutamide in cytochrome P450 1A2 knockout SV129 mice

K. Nishikawa, Y. Matsuzaki, D. Nagai, 2006, Journal of Gastroenterology.

Highly sensitive assay of HMG-CoA reductase activity by LC-ESI-MS/MS Published, JLR Papers in Press, February 1, 2007.

A. Honda, Y. Matsuzaki, T. Ikegami, 2007, Journal of Lipid Research.

Effects of taurine administration in rat skeletal muscles on exercise

T. Miyazaki, Y. Matsuzaki, N. Ochiai, 2003, Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association.

The role of taurine on skeletal muscle cell differentiation.

T. Miyazaki, A. Honda, Y. Matsuzaki, 2013, Advances in experimental medicine and biology.

Effect of BCAA supplement timing on exercise-induced muscle soreness and damage: a pilot placebo-controlled double-blind study.

T. Miyazaki, A. Honda, Y. Matsuzaki, 2018, The Journal of sports medicine and physical fitness.

Increased N-Acetyltaurine in the Skeletal Muscle After Endurance Exercise in Rat.

T. Miyazaki, A. Honda, Y. Matsuzaki, 2018, Advances in experimental medicine and biology.

Short-term effects of 3-hydroxy-3-methylglutaryl-CoA reductase inhibitor on cholesterol and bile acid synthesis in humans

A. Honda, N. Tanaka, Y. Matsuzaki, 1997, Lipids.

Hepatic cholesterol and bile acid synthesis in Japanese patients with cholesterol gallstones

A. Honda, N. Tanaka, Y. Matsuzaki, 1993, Gastroenterologia Japonica.

Increased bile acid concentration in liver tissue with cholesterol gallstone disease

A. Honda, N. Tanaka, Y. Matsuzaki, 2005, Journal of Gastroenterology.

Significance of plasma 7α-hydroxy-4-cholesten-3-one and 27-hydroxycholesterol concentrations as markers for hepatic bile acid synthesis in cholesterol-fed rabbits☆

A. Honda, N. Tanaka, Y. Matsuzaki, 2004 .

Highly sensitive quantification of serum malonate, a possible marker for de novo lipogenesis, by LC-ESI-MS/MS

T. Miyazaki, A. Honda, Takeshi Hirayama, 2009, Journal of Lipid Research.

Degeneration of skeletal muscle fibers in the rat administrated carbon tetrachloride: similar histological findings of the muscle in a 64-year-old patient of LC with muscle cramp.

T. Miyazaki, N. Tanaka, Y. Matsuzaki, 2002, Hepatology research : the official journal of the Japan Society of Hepatology.

Anti-proliferative action of endogenous dehydroepiandrosterone metabolites on human cancer cell lines

A. Honda, S. Yoshida, N. Tanaka, 2003, Steroids.

Pathophysiological analysis of primary biliary cirrhosis focusing on choline/phospholipid metabolism

Y. Maehara, K. Shirabe, K. Kotoh, 2015, Liver international : official journal of the International Association for the Study of the Liver.

Etiologic significance of defects in cholesterol, phospholipid, and bile acid metabolism in the liver of patients with intrahepatic calculi

Y. Sugiyama, Y. Nimura, N. Tanaka, 2001, Hepatology.

Effects of long‐term ursodeoxycholate administration on expression levels of secretory low–molecular‐weight phospholipases A and mucin genes in gallbladders and biliary composition in patients with multiple cholesterol stones

T. Irimura, N. Tanaka, Y. Matsuzaki, 1998, Hepatology.

Effects of Zinc Acetate on Serum Zinc Concentrations in Chronic Liver Diseases: a Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial and a Dose Adjustment Trial

Y. Takikawa, K. Hosho, Y. Matsuzaki, 2019, Biological Trace Element Research.

Efficacy and safety of ombitasvir/paritaprevir/ritonavir in dialysis patients with genotype 1b chronic hepatitis C

A. Tsubota, Y. Matsuzaki, K. Iwakiri, 2017, Hepatology research : the official journal of the Japan Society of Hepatology.

Efficacy and safety of ombitasvir / paritaprevir / ritonavir in dialysis patients with genotype 1 b chronic hepatitis C Short running title : ombitasvir / paritaprevir / ritonavir for dialysis patients

A. Tsubota, Y. Matsuzaki, K. Iwakiri, 2017 .

Regulation of 25- and 27-hydroxylation side chain cleavage pathways for cholic acid biosynthesis in humans, rabbits, and mice. Assay of enzyme activities by high-resolution gas chromatography;-mass spectrometry.

A. Honda, N. Tanaka, Y. Matsuzaki, 2000, Journal of lipid research.

Ursodeoxycholic acid: Mechanism of action and novel clinical applications

Y. Matsuzaki, T. Ikegami, 2007, Hepatology research : the official journal of the Japan Society of Hepatology.

Colestimide: The efficacy of a novel anion‐exchange resin in cholestatic disorders

Y. Matsuzaki, 2002, Journal of gastroenterology and hepatology.

The efficacy of powerful proton radiotherapy for hepatocellular carcinoma

Y. Matsuzaki, 1998 .

Effective gene therapy of biliary tract cancers by a conditionally replicative adenovirus expressing uracil phosphoribosyltransferase: significance of timing of 5-fluorouracil administration.

N. Tanaka, Y. Matsuzaki, H. Hamada, 2005, Cancer research.

5-Fluorouracil Administration Phosphoribosyltransferase : Significance of Timing of Conditionally Replicative Adenovirus Expressing Uracil Effective Gene Therapy of Biliary Tract Cancers by a

N. Tanaka, Y. Matsuzaki, H. Hamada, 2005 .

Progression of autoimmune-mediated hepatic lesions in a murine graft-versus-host reaction by neutralizing IL-10.

N. Tanaka, Y. Matsuzaki, M. Doy, 2003, Hepatology research : the official journal of the Japan Society of Hepatology.

Intestinal Digestion and Absorption

A. Honda, Y. Matsuzaki, T. Ikegami, 2017 .

Significance of plasma 7alpha-hydroxy-4-cholesten-3-one and 27-hydroxycholesterol concentrations as markers for hepatic bile acid synthesis in cholesterol-fed rabbits.

A. Honda, N. Tanaka, Y. Matsuzaki, 2004, Metabolism: clinical and experimental.

Simultaneous quantification of salivary 3-hydroxybutyrate, 3-hydroxyisobutyrate, 3-hydroxy-3-methylbutyrate, and 2-hydroxybutyrate as possible markers of amino acid and fatty acid catabolic pathways by LC–ESI–MS/MS

T. Miyazaki, A. Honda, Takeshi Hirayama, 2015, SpringerPlus.

Dehydroepiandrosterone and its derivatives: potentially novel anti-proliferative and chemopreventive agents.

A. Honda, Y. Matsuzaki, 2006, Current pharmaceutical design.

Hepatitis C virus infection causes hypolipidemia regardless of hepatic damage or nutritional state: An epidemiological survey of a large Japanese cohort

T. Miyazaki, A. Honda, Takeshi Hirayama, 2011, Hepatology research : the official journal of the Japan Society of Hepatology.

The Effects of Cyclooxygenase2–ProstaglandinE2 Pathway on Helicobacter pylori‐Induced Urokinase‐Type Plasminogen Activator System in the Gastric Cancer Cells

Y. Matsuzaki, J. Iwamoto, Y. Mizokami, 2008, Helicobacter.

Increased N-acetyltaurine in serum and urine after endurance exercise in human.

T. Miyazaki, A. Honda, Y. Matsuzaki, 2015, Advances in experimental medicine and biology.

Changes in the liver parenchyma after proton beam radiotherapy: evaluation with MR imaging.

Y. Itai, H. Yoshioka, Y. Akine, 2000, Magnetic resonance imaging.

Expression of Cytochrome P450 3A4 in Foveolar Epithelium with Intestinal Metaplasia of the Human Stomach

Y. Matsuzaki, M. Kakiki, T. Yokose, 1998, Japanese journal of cancer research : Gann.

Cytokine profile of liver‐infiltrating CD4+ T cells separated from murine primary biliary cirrhosis‐like hepatic lesions induced by graft‐versus‐host reaction

N. Tanaka, Y. Matsuzaki, T. Ikegami, 2000, Journal of gastroenterology and hepatology.

Effect of native vitamin D3 supplementation on refractory chronic hepatitis C patients in simeprevir with pegylated interferon/ribavirin

A. Tsubota, Y. Matsuzaki, K. Iwakiri, 2016, Hepatology research : the official journal of the Japan Society of Hepatology.

Influence of chemotherapeutic agents and cytokines on the expression of 5-fluorouracil-associated enzymes in human colon cancer cell lines

H. Matsui, Y. Matsuzaki, A. Yanaka, 2006, Journal of Gastroenterology.

Decreased taurine concentration in skeletal muscles after exercise for various durations.

T. Miyazaki, N. Tanaka, Y. Matsuzaki, 2002, Medicine and science in sports and exercise.

Therapeutic barium enema for bleeding colonic diverticula: four case series and review of the literature.

Y. Matsuzaki, J. Iwamoto, Y. Mizokami, 2008, World journal of gastroenterology.

Analysis of factors predicting the response to tolvaptan in patients with liver cirrhosis and hepatic edema

A. Tsubota, Y. Matsuzaki, K. Iwakiri, 2018, Journal of gastroenterology and hepatology.

Suppressive effect of ursodeoxycholic acid on type IIA phospholipase A2 expression in HepG2 cells

N. Tanaka, Y. Matsuzaki, J. Olivier, 2005, Hepatology.

Simultaneous determination of dehydroepiandrosterone and its 7-oxygenated metabolites in human serum by high-resolution gas chromatography–mass spectrometry

T. Miyazaki, A. Honda, S. Yoshida, 2004, Steroids.

Synthesis of serum and cytosol vitamin D-binding proteins by rat liver and kidney.

Y. Matsuzaki, T. Osuga, K. Mitamura, 1982, The Journal of biological chemistry.

Increased expression of gallbladder cholecystokinin: a receptor in prairie dogs fed a high-cholesterol diet and its dissociation with decreased contractility in response to cholecystokinin.

N. Tanaka, Y. Matsuzaki, J. Shoda, 2002, Journal of Laboratory and Clinical Medicine.

Miconazole Gel Increases the Cure Rate of Helicobacter pylori Infection When Added to Lansoprazole and Amoxicillin in a Randomized Trial

Y. Matsuzaki, A. Yanaka, A. Nakahara, 1998, Helicobacter.

Severe acute hepatitis A associated with acute pure red cell aplasia

N. Tanaka, Y. Matsuzaki, M. Nishi, 1996, Journal of Gastroenterology.

Novel murine autoimmune‐mediated liver disease model induced by graft‐versus‐host reaction and concanavalin A

N. Tanaka, Y. Matsuzaki, M. Doy, 2001, Journal of gastroenterology and hepatology.

Green tea polyphenol (epigallocatechin-3-gallate) improves gut dysbiosis and serum bile acids dysregulation in high-fat diet-fed mice

Y. Naito, A. Honda, Y. Matsuzaki, 2019, Journal of clinical biochemistry and nutrition.

Liquid Chromatography Assay for Routine Monitoring of Cellular Ribavirin Levels in Blood

N. Tanaka, Y. Matsuzaki, Takayoshi Ito, 2004, Antimicrobial Agents and Chemotherapy.

Alcohol abuse and occult HBV-a risk factor for hepatocellular carcinoma.

Y. Matsuzaki, 2005, Hepatology research : the official journal of the Japan Society of Hepatology.

Impact of determination of hepatitis B virus subgenotype and pre‐core/core‐promoter mutation for the prediction of acute exacerbation of asymptomatic carriers

M. Mizokami, Yasuhito Tanaka, A. Honda, 2009, Hepatology research : the official journal of the Japan Society of Hepatology.

Identification of novel hepatitis C virus-specific cytotoxic T lymphocyte epitopes by ELISpot assay using peptides with human leukocyte antigen-A*2402-binding motifs.

N. Tanaka, Y. Matsuzaki, I. Nakamura, 2004, The Journal of general virology.

Marked elevation of erythrocyte ribavirin levels in interferon and ribavirin-induced anemia.

N. Tanaka, Y. Matsuzaki, M. Homma, 2004, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Analysis of 307 cases with drug‐induced liver injury between 2010 and 2018 in Japan

S. Kaneko, Y. Hiasa, Y. Takei, 2019, Hepatology research : the official journal of the Japan Society of Hepatology.

The associated markers and their limitations for the primary screening of HCV carriers in public health examination

T. Miyazaki, A. Honda, Takeshi Hirayama, 2009, Hepatology research : the official journal of the Japan Society of Hepatology.

Enhancement of DNA topoisomerase I inhibitor–induced apoptosis by ursodeoxycholic acid

Y. Matsuzaki, B. Bouscarel, S. Ceryak, 2006, Molecular Cancer Therapeutics.

Small-bowel mucosal injuries in low-dose aspirin users with obscure gastrointestinal bleeding.

A. Honda, Y. Matsuzaki, Y. Saito, 2014, World journal of gastroenterology.

Bezafibrate Improves GLOBE and UK‐PBC Scores and Long‐Term Outcomes in Patients With Primary Biliary Cholangitis

H. Yoshiji, T. Masaki, Y. Takikawa, 2019, Hepatology.

Altered metabolism of bile acids in cholestasis: Determination of 1β- and 6α-hydroxylated metabolites

N. Tanaka, Y. Matsuzaki, T. Osuga, 1989 .

Serum carnitine as an independent biomarker of malnutrition in patients with impaired oral intake

T. Miyazaki, A. Honda, Y. Matsuzaki, 2014, Journal of clinical biochemistry and nutrition.

Rebamipide Significantly Inhibits Indomethacin-Induced Mitochondrial Damage, Lipid Peroxidation, and Apoptosis in Gastric Epithelial RGM-1 Cells

H. Matsui, Yukio Nakamura, Y. Matsuzaki, 2005, Digestive Diseases and Sciences.

Neoplastic transformation and induction of H+,K+-adenosine triphosphatase by N-methyl-N′-nitro-N-nitrosoguanidine in the gastric epithelial RGM-1 cell line

H. Matsui, I. Hyodo, H. Majima, 2007, In Vitro Cellular & Developmental Biology - Animal.

Angiomyolipoma of the liver: significance of CT and MR dynamic study

Y. Itai, H. Onaya, N. Tanaka, 1998, Abdominal Imaging.

A case of metastatic gastric tumor of the lung primary that caused significant bleeding

A. Honda, Takeshi Hirayama, Y. Matsuzaki, 2015 .

Regulation of cholesterol biosynthetic pathway in patients with the Smith–Lemli–Opitz syndrome

A. Honda, N. Tanaka, Y. Matsuzaki, 2000, Journal of Inherited Metabolic Disease.

Proton beam therapy for large hepatocellular carcinoma.

M. Tokita, Y. Matsuzaki, K. Tsuboi, 2010, International journal of radiation oncology, biology, physics.

Repeated proton beam therapy for hepatocellular carcinoma.

T. Hashimoto, K. Kagei, Y. Akine, 2005, International journal of radiation oncology, biology, physics.

Proton beam therapy for hepatocellular carcinoma with portal vein tumor thrombus

T. Hashimoto, K. Kagei, Y. Akine, 2005, Cancer.

Monitoring of hepatocellular carcinoma, following proton radiotherapy, with contrast-enhanced color Doppler ultrasonography

Yasuyo Kita, Takashi Kurosawa, Yoshifumi Saito, 2005, Journal of Gastroenterology.

Proton-Beam Therapy for Hepatocellular Carcinoma Associated with Portal Vein Tumor Thrombosis*

M. Tokita, Y. Matsuzaki, K. Tsuboi, 2009, Strahlentherapie und Onkologie.

Proton Beam Therapy for Hepatocellular Carcinoma: A Retrospective Review of 162 Patients

K. Kagei, Y. Akine, H. Igaki, 2005, Clinical Cancer Research.

Proton beam therapy for hepatocellular carcinoma with limited treatment options

T. Hashimoto, Y. Akine, Y. Matsuzaki, 2006, Cancer.

Effects of the Concomitant Use of Low-dose Clarithromycin with an Anti-TNFα Antibody in a Patient with Intestinal Behçet Disease

A. Honda, Takeshi Hirayama, Y. Matsuzaki, 2017, Internal medicine.

Involvement of integrin‐linked kinase in carbon tetrachloride–induced hepatic fibrosis in rats

I. Hyodo, T. Miyazaki, A. Honda, 2006, Hepatology.

Taurine and liver diseases: a focus on the heterogeneous protective properties of taurine

T. Miyazaki, Y. Matsuzaki, 2012, Amino Acids.

Secretory low–molecular‐weight phospholipases A2 and their specific receptor in bile ducts of patients with intrahepatic calculi: Factors of chronic proliferative cholangitis

T. Irimura, N. Tanaka, Y. Matsuzaki, 1999, Hepatology.

A case of Behçet's syndrome with esophageal involvement treated with salicylazosulfapyridine and prednisolone.

Y. Matsuzaki, A. Yanaka, A. Nakahara, 1998, Endoscopy.

Safety and effectiveness of sorafenib in Japanese patients with hepatocellular carcinoma in daily medical practice: interim analysis of a prospective postmarketing all-patient surveillance study

S. Kaneko, J. Furuse, K. Okita, 2016, Journal of Gastroenterology.

The expression levels of plasma membrane transporters in the cholestatic liver of patients undergoing biliary drainage and their association with the impairment of biliary secretory function.

Y. Sugiyama, Y. Nimura, N. Tanaka, 2001 .

Clinical significance of serum total bile acids and indocyanine green test for the estimation of plasma free etoposide ratio in anicteric hepatocellular carcinoma patients

N. Tanaka, Y. Matsuzaki, Kunihiko Kobayashi, 1997 .

Differences in the Serum 4β-hydroxycholesterol Levels of Patients with Chronic Hepatitis C Virus (HCV) Infection: A Possible Impact on the Efficacy and Safety of Interferon (IFN)-free Treatment

T. Miyazaki, A. Honda, Takeshi Hirayama, 2017, Internal medicine.

Differences in the Serum 4β-hydroxycholesterol Levels of Patients with Chronic HCV Infection: A Possible Impact on the Efficacy and Safety of IFN-free Treatment

T. Miyazaki, A. Honda, Takeshi Hirayama, 2017 .

AUTOIMMUNE , CHOLESTATIC , AND BILIARY DISEASE Anticholestatic Effects of Bezafibrate in Patients with Primary Biliary Cirrhosis Treated with Ursodeoxycholic Acid

T. Miyazaki, A. Honda, Takeshi Hirayama, 2013 .

Novel mutations identified in the human multidrug resistance-associated protein 2 (MRP2/ABCC2) gene in a Japanese patient with Dubin-Johnson syndrome.

Y. Sugiyama, N. Tanaka, Y. Matsuzaki, 2003, Hepatology research : the official journal of the Japan Society of Hepatology.

Hepatocellular carcinoma development in diabetic patients: a nationwide survey in Japan

H. Nomura, H. Yoshiji, M. Matsuda, 2021, Journal of Gastroenterology.

Erythrocyte ribavirin concentration for assessing hemoglobin reduction in interferon and ribavirin combination therapy.

Y. Matsuzaki, Takayoshi Ito, M. Homma, 2006, Hepatology research : the official journal of the Japan Society of Hepatology.

Utility of serum CA 19-9 monitoring in preoperative radiotherapy for pancreatic cancer.

Y. Itai, Y. Matsuzaki, K. Ohara, 2001, Hepato-gastroenterology.

Alterations of bile acid composition in gallstones, bile, and liver of patients with hepatolithiasis, and their etiological significance

N. Tanaka, Y. Matsuzaki, T. Osuga, 1993, Digestive Diseases and Sciences.

Bicarbonate Attenuates Irinotecan-Induced Cytotoxicity through Regulation of Both Extracellular and Intracellular pHs in Intestine Cell Line

T. Miyazaki, Y. Matsuzaki, Kunihiko Kobayashi, 2013 .

Detection of Gut Dysbiosis due to Reduced Clostridium Subcluster XIVa Using the Fecal or Serum Bile Acid Profile.

T. Miyazaki, A. Honda, Takeshi Hirayama, 2018, Inflammatory bowel diseases.

Protective effect of agaro-oligosaccharides on gut dysbiosis and colon tumorigenesis in high-fat diet-fed mice.

Yuji Naito, Toshikazu Yoshikawa, Madoka Yasui, 2016, American journal of physiology. Gastrointestinal and liver physiology.

Multiple regression analysis for assessing the growth of small hepatocellular carcinoma: The MIB-1 labeling index is the most effective parameter

N. Tanaka, Y. Matsuzaki, Y. Saito, 1998, Journal of Gastroenterology.

The comparison of the intensity of human intestinal spirochetes between Brachyspira pilosicoli and Brachyspira aalborgi infections

A. Honda, Y. Matsuzaki, J. Iwamoto, 2018, Journal of clinical biochemistry and nutrition.

Human intestinal spirochaetosis in two ulcerative colitis patients.

A. Honda, Y. Matsuzaki, Y. Saito, 2014, Internal medicine.

Long‐term ursodeoxycholic acid therapy is associated with reduced risk of biliary pain and acute cholecystitis in patients with gallbladder stones: A cohort analysis

N. Tanaka, Y. Matsuzaki, T. Osuga, 1999, Hepatology.

Abstracts of selected papers presented at the 29th Annual Meeting of the Japanese Society of Gastroenterology

T. Saibara, T. Kashiwagi, Y. Nakanuma, 2007, Gastroenterologia Japonica.

Accumulation of 7α-hydroxycholesterol in liver tissue of patients with cholesterol gallstones

A. Honda, N. Tanaka, Y. Matsuzaki, 1995, Journal of Gastroenterology.

Proton beam therapy for hepatocellular carcinoma located adjacent to the alimentary tract.

H. Sakurai, Y. Matsuzaki, K. Tsuboi, 2011, International journal of radiation oncology, biology, physics.

Proton Beam Therapy for Hepatocellular Carcinoma: A Retrospective Review of 162 Patients

K. Kagei, Y. Akine, H. Igaki, 2005, Clinical Cancer Research.

Additional effects of taurine on the benefits of BCAA intake for the delayed-onset muscle soreness and muscle damage induced by high-intensity eccentric exercise.

T. Miyazaki, Y. Matsuzaki, S. Maeda, 2013, Advances in experimental medicine and biology.

Abstracts of selected papers presented at the 72nd General Meeting of the Japanese Society of Gastroenterology Niigata, Japan, March 27–29, 1986

K. Hatakeyama, M. Sugiura, H. Mieno, 1987, Gastroenterologia Japonica.

Taurine inhibits oxidative damage and prevents fibrosis in carbon tetrachloride-induced hepatic fibrosis.

T. Miyazaki, N. Tanaka, Y. Matsuzaki, 2005, Journal of hepatology.

Effect of ursodeoxycholic acid in chronic hepatitis and primary biliary cirrhosis

N. Tanaka, Y. Matsuzaki, T. Osuga, 1989, Digestive Diseases and Sciences.

Clinical feature of a small intestinal mucosal injury in chronic NSAID users in Japan.

A. Honda, Y. Matsuzaki, Y. Saito, 2012, Journal of gastrointestinal and liver diseases : JGLD.

Cholesterol and chronic hepatitis C virus infection

A. Honda, Y. Matsuzaki, 2011, Hepatology research : the official journal of the Japan Society of Hepatology.

[Dose-volume histogram analysis of patients with hepatocellular carcinoma regarding changes in liver function after proton therapy].

H. Tsujii, N. Tanaka, Y. Matsuzaki, 1995, Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica.

Clinical results of proton radiotherapy for hepatocellular carcinoma

T. Hashimoto, K. Kagei, Y. Akine, 2003 .

Influences of Taurine Deficiency on Bile Acids of the Bile in the Cat Model.

T. Miyazaki, A. Honda, Y. Matsuzaki, 2019, Advances in experimental medicine and biology.

The efficacy and safety of terlipressin and albumin in patients with type 1 hepatorenal syndrome: a multicenter, open-label, explorative study

O. Yokosuka, K. Okita, Y. Matsuzaki, 2012, Journal of Gastroenterology.

Regulation of taurine conjugation and biosynthesis by bile acids through farnesoid X receptor activation

T. Miyazaki, A. Honda, Y. Matsuzaki, 2014, Hepatology research : the official journal of the Japan Society of Hepatology.

Changes in G protein expression account for impaired modulation of hepatic cAMP formation after BDL.

Y. Matsuzaki, T. Gettys, B. Bouscarel, 1998, The American journal of physiology.

Randomized control trial of lipo‐prostaglandin E1 in patients with acute liver injury induced by Lipiodol‐targeted chemotherapy

N. Tanaka, Y. Matsuzaki, Y. Saito, 1995, Clinical pharmacology and therapeutics.

The efficacy and safety of terlipressin and albumin in patients with type 1 hepatorenal syndrome: a multicenter, open-label, explorative study Yoshiyuki NaraharaHidenori KanazawaChoitsu SakamotoHitoshi Maruyama • Osamu YokosukaSatoshi MochidaMasahito UemuraHiroshi FukuiYasukiyo Sumino •

O. Yokosuka, K. Okita, Y. Matsuzaki, 2011 .

Hypercholesterolemia in rats with hepatomas: Increased oxysterols accelerate efflux but do not inhibit biosynthesis of cholesterol

T. Miyazaki, A. Honda, Takeshi Hirayama, 2006, Hepatology.

Symptoms and health-related quality of life in Japanese patients with primary biliary cholangitis

H. Yoshiji, A. Komori, A. Takaki, 2018, Scientific Reports.

Proton Beam Therapy for Hepatocellular Carcinoma Patients with Severe Cirrhosis

T. Hashimoto, Y. Akine, Y. Matsuzaki, 2006, Strahlentherapie und Onkologie.

The clinical outcome of capsule endoscopy in patients with obscure gastrointestinal bleeding.

A. Honda, Takeshi Hirayama, Y. Matsuzaki, 2011, Hepato-gastroenterology.

Comparative study between public and occupational health examinations in Ibaraki Prefecture

T. Miyazaki, A. Honda, Y. Matsuzaki, 2010 .

Rapid inhibition of MAPK signaling and anti-proliferation effect via JAK/STAT signaling by interferon-alpha in hepatocellular carcinoma cell lines.

A. Honda, N. Tanaka, Y. Matsuzaki, 2005, Biochimica et biophysica acta.

Bile Acid Malabsorption Deactivates Pregnane X Receptor in Patients with Crohn’s Disease

T. Miyazaki, A. Honda, Y. Matsuzaki, 2013, Inflammatory bowel diseases.

Focused radiation hepatitis after Bragg-peak proton therapy for hepatocellular carcinoma: CT findings.

Y. Itai, H. Tsujii, Y. Matsuzaki, 1994, Journal of computer assisted tomography.

Effect of cholestasis on regulation of cAMP synthesis by glucagon and bile acids in isolated hepatocytes.

Y. Matsuzaki, T. Gettys, B. Bouscarel, 1997, American Journal of Physiology.

Proton irradiation for hepatocellular carcinoma

H. Tsujii, N. Tanaka, Y. Matsuzaki, 1992, The Lancet.

Plasma levels of mevalonate and 7α‐hydroxy‐4‐cholesten‐3‐one in chronic liver disease

A. Honda, N. Tanaka, Y. Matsuzaki, 1999, Journal of gastroenterology and hepatology.

Powerful radiotherapy for hepatocellular carcinoma

Y. Matsuzaki, 1999, Journal of gastroenterology and hepatology.

Anti‐gp210 and anti‐centromere antibodies for the prediction of PBC patients with an incomplete biochemical response to UDCA and bezafibrate

A. Honda, Y. Matsuzaki, T. Ikegami, 2015, Hepatology research : the official journal of the Japan Society of Hepatology.

Dietary amelioration of Helicobacter pylori infection: design criteria for a clinical trial.

A. Muñoz, Y. Matsuzaki, J. Fahey, 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

The effect of metoclopramide in capsule endoscopy.

A. Honda, Takeshi Hirayama, Y. Matsuzaki, 2010, Hepato-Gastroenterology.

The role of previous hepatitis B virus infection and heavy smoking in hepatitis C virus-related hepatocellular carcinoma.

N. Tanaka, Y. Matsuzaki, T. Chiba, 1996, The American journal of gastroenterology.

A new, effective, and safe therapeutic option using proton irradiation for hepatocellular carcinoma.

H. Tsujii, N. Tanaka, Y. Matsuzaki, 1994, Gastroenterology.

Serum concentration of 27‐hydroxycholesterol predicts the effects of high‐cholesterol diet on plasma LDL cholesterol level

T. Miyazaki, A. Honda, Takeshi Hirayama, 2009, Hepatology research : the official journal of the Japan Society of Hepatology.

Pretreatment methods in transnasal endoscopy.

A. Honda, Takeshi Hirayama, Y. Matsuzaki, 2011, Hepato-gastroenterology.

Simultaneous assay of the activities of two key enzymes in cholesterol metabolism by gas chromatography-mass spectrometry.

N. Shigematsu, A. Honda, N. Tanaka, 1991, Journal of chromatography.

Does ursodeoxycholic acid cause lichenoid eruption?

Y. Matsuzaki, H. Takikawa, Tadashi Yoshida, 2002, Gastroenterology.

Proton beam therapy for large hepatocellular carcinoma.

M. Tokita, Y. Matsuzaki, K. Tsuboi, 2010, International journal of radiation oncology, biology, physics.

New, effective treatment using proton irradiation for unresectable hepatocellular carcinoma.

Y. Itai, H. Tsujii, N. Tanaka, 1995, Internal medicine.

The chemopreventive role of ursodeoxycholic acid in azoxymethane-treated rats: suppressive effects on enhanced group II phospholipase A2 expression in colonic tissue.

N. Tanaka, Y. Matsuzaki, T. Ikegami, 1998, Cancer letters.